https://www.taxtmi.com/news?id=69578 The Budget provides a Rs 10,000 crore Biopharma Shakti initiative to expand domestic biologics and biosimilars production and reduce import dependence, introduces customs duty exemptions on select cancer drugs to lower patient costs, and establishes five regional medical hubs to enhance access to advanced diagnostics, treatment, rehabilitation, employment, and medical tourism while emphasising geriatric and home based care and integration of modern medicine with traditional therapies. en-us Sun, 01 Feb 2026 20:01:04 +0530 Sun, 01 Feb 2026 20:01:05 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=69578 The Budget provides a Rs 10,000 crore Biopharma Shakti initiative to expand domestic biologics and biosimilars production and reduce import dependence, introduces customs duty exemptions on select cancer drugs to lower patient costs, and establishes five regional medical hubs to enhance access to advanced diagnostics, treatment, rehabilitation, employment, and medical tourism while emphasising geriatric and home based care and integration of modern medicine with traditional therapies. News - Sun, 01 Feb 2026 20:01:04 +0530 https://www.taxtmi.com/news?id=69578